A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response

Abstract The African swine fever (ASF) pandemics pose a significant threat to the global swine industry, and the development of safe and effective vaccines is a daunting but necessary challenge. The level and persistence of immunity are very important for the effectiveness of the vaccine. Targeting...

Full description

Bibliographic Details
Main Authors: Jinxing Song, Mengxiang Wang, Lei Zhou, Panpan Tian, ZhuoYa Sun, Junru Sun, Xuannian Wang, Guoqing Zhuang, Dawei Jiang, Yanan Wu, Gaiping Zhang
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-023-02210-9
_version_ 1797556689060233216
author Jinxing Song
Mengxiang Wang
Lei Zhou
Panpan Tian
ZhuoYa Sun
Junru Sun
Xuannian Wang
Guoqing Zhuang
Dawei Jiang
Yanan Wu
Gaiping Zhang
author_facet Jinxing Song
Mengxiang Wang
Lei Zhou
Panpan Tian
ZhuoYa Sun
Junru Sun
Xuannian Wang
Guoqing Zhuang
Dawei Jiang
Yanan Wu
Gaiping Zhang
author_sort Jinxing Song
collection DOAJ
description Abstract The African swine fever (ASF) pandemics pose a significant threat to the global swine industry, and the development of safe and effective vaccines is a daunting but necessary challenge. The level and persistence of immunity are very important for the effectiveness of the vaccine. Targeting antigens to antigen presenting cells (APCs) can greatly enhance immunogenicity. In this study, we developed a self-assembled nano-ASFV vaccine candidate (NanoFVax) targeting DCs, by covalently coupling the self-assembled 24-mer ferritin with the dominant B and T cell epitopes of the highly immunogenic ASFV antigen (p72, CD2v, pB602L and p30) and fused with the chemokine receptor XCL1 (a DC targeting molecule) through the SpyTag/SpyCatcher protein ligase system. Compared to monomeric protein, the nanoparticle vaccines can induce a more robust T-cell response, and the high-level antibody response against ASFV can last for more than 231 days. Therefore, the NanoFVax is a novel and promising vaccine candidate for ASFV. Graphical Abstract
first_indexed 2024-03-10T17:05:27Z
format Article
id doaj.art-0265e384dd1a478c9bafc16ac9899bb0
institution Directory Open Access Journal
issn 1477-3155
language English
last_indexed 2024-03-10T17:05:27Z
publishDate 2023-11-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj.art-0265e384dd1a478c9bafc16ac9899bb02023-11-20T10:48:21ZengBMCJournal of Nanobiotechnology1477-31552023-11-0121111810.1186/s12951-023-02210-9A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune responseJinxing Song0Mengxiang Wang1Lei Zhou2Panpan Tian3ZhuoYa Sun4Junru Sun5Xuannian Wang6Guoqing Zhuang7Dawei Jiang8Yanan Wu9Gaiping Zhang10International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityInternational Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural UniversityAbstract The African swine fever (ASF) pandemics pose a significant threat to the global swine industry, and the development of safe and effective vaccines is a daunting but necessary challenge. The level and persistence of immunity are very important for the effectiveness of the vaccine. Targeting antigens to antigen presenting cells (APCs) can greatly enhance immunogenicity. In this study, we developed a self-assembled nano-ASFV vaccine candidate (NanoFVax) targeting DCs, by covalently coupling the self-assembled 24-mer ferritin with the dominant B and T cell epitopes of the highly immunogenic ASFV antigen (p72, CD2v, pB602L and p30) and fused with the chemokine receptor XCL1 (a DC targeting molecule) through the SpyTag/SpyCatcher protein ligase system. Compared to monomeric protein, the nanoparticle vaccines can induce a more robust T-cell response, and the high-level antibody response against ASFV can last for more than 231 days. Therefore, the NanoFVax is a novel and promising vaccine candidate for ASFV. Graphical Abstracthttps://doi.org/10.1186/s12951-023-02210-9African swine feverNanoparticlesXCL1NanoFVaxFerritinVaccine candidate
spellingShingle Jinxing Song
Mengxiang Wang
Lei Zhou
Panpan Tian
ZhuoYa Sun
Junru Sun
Xuannian Wang
Guoqing Zhuang
Dawei Jiang
Yanan Wu
Gaiping Zhang
A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
Journal of Nanobiotechnology
African swine fever
Nanoparticles
XCL1
NanoFVax
Ferritin
Vaccine candidate
title A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
title_full A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
title_fullStr A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
title_full_unstemmed A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
title_short A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response
title_sort candidate nanoparticle vaccine comprised of multiple epitopes of the african swine fever virus elicits a robust immune response
topic African swine fever
Nanoparticles
XCL1
NanoFVax
Ferritin
Vaccine candidate
url https://doi.org/10.1186/s12951-023-02210-9
work_keys_str_mv AT jinxingsong acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT mengxiangwang acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT leizhou acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT panpantian acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT zhuoyasun acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT junrusun acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT xuannianwang acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT guoqingzhuang acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT daweijiang acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT yananwu acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT gaipingzhang acandidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT jinxingsong candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT mengxiangwang candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT leizhou candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT panpantian candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT zhuoyasun candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT junrusun candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT xuannianwang candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT guoqingzhuang candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT daweijiang candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT yananwu candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse
AT gaipingzhang candidatenanoparticlevaccinecomprisedofmultipleepitopesoftheafricanswinefeverviruselicitsarobustimmuneresponse